Np mrd loader

Record Information
Version2.0
Created at2024-09-11 17:09:42 UTC
Updated at2024-09-11 17:09:42 UTC
NP-MRD IDNP0338705
Secondary Accession NumbersNone
Natural Product Identification
Common NameLevothyroxine
Description Levothyroxine was first documented in 2024 (PMID: 39307136). Based on a literature review a small amount of articles have been published on Levothyroxine (PMID: 39295705) (PMID: 39290156) (PMID: 39287310) (PMID: 39286238).
Structure
Thumb
SynonymsNot Available
Chemical FormulaC15H11I4NO4
Average Mass776.8740 Da
Monoisotopic Mass776.68669 Da
IUPAC Name2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid
Traditional Namethyroxine
CAS Registry NumberNot Available
SMILES
NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O
InChI Identifier
InChI=1/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)
InChI KeyXUIIKFGFIJCVMT-UHFFFAOYNA-N
Experimental Spectra
Not Available
Predicted Spectra
Not Available
Chemical Shift Submissions
Not Available
Species
Species of OriginNot Available
Chemical Taxonomy
DescriptionThis compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentPhenylalanine and derivatives
Alternative Parents
Substituents
  • Phenylalanine or derivatives
  • Diphenylether
  • Diaryl ether
  • 3-phenylpropanoic-acid
  • Alpha-amino acid
  • Amphetamine or derivatives
  • Phenoxy compound
  • 2-iodophenol
  • 2-halophenol
  • Phenol ether
  • Iodobenzene
  • Halobenzene
  • Aralkylamine
  • Phenol
  • Aryl halide
  • Aryl iodide
  • Monocyclic benzene moiety
  • Benzenoid
  • Amino acid
  • Monocarboxylic acid or derivatives
  • Ether
  • Carboxylic acid
  • Organic nitrogen compound
  • Primary aliphatic amine
  • Organohalogen compound
  • Organoiodide
  • Organonitrogen compound
  • Organooxygen compound
  • Primary amine
  • Carbonyl group
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Organic oxygen compound
  • Amine
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External Descriptors
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP3.73ChemAxon
pKa (Strongest Acidic)0.27ChemAxon
pKa (Strongest Basic)9.43ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area92.78 ŲChemAxon
Rotatable Bond Count5ChemAxon
Refractivity126.79 m³·mol⁻¹ChemAxon
Polarizability49.38 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkLevothyroxine
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Wang J, Hao J, Gao Y, Wang S, Wang D, Tao W, Duan R, Zhang Z, Gao M: Application value of iodine-131 combined with levothyroxine sodium in patients with differentiated thyroid cancer after surgery. Oncology. 2024 Sep 20:1-15. doi: 10.1159/000541546. [PubMed:39307136 ]
  2. Alshaakh Mohd Mari A, Titus J, Zayat V, Kinaan M: A Malignant Duo: Mixed Medullary and Follicular Variant Papillary Thyroid Cancer. Cureus. 2024 Aug 19;16(8):e67231. doi: 10.7759/cureus.67231. eCollection 2024 Aug. [PubMed:39295705 ]
  3. de Lima Beltrao FE, Carvalhal G, de Almeida Beltrao DC, de Lima Beltrao FE, Ribeiro MO, Ettleson MD, Ramos HE, Bianco AC: Treatment Preferences in Patients with Hypothyroidism: an Analysis of Eleven Randomized Controlled Trials. J Clin Endocrinol Metab. 2024 Sep 18:dgae651. doi: 10.1210/clinem/dgae651. [PubMed:39290156 ]
  4. Lin H, Zhang X, Zheng Y, Tang C, Wang J: Research on the soothing Liver - Qi stagnation method in the treatment of postoperative papillary thyroid carcinoma patients' concomitant depression: A randomized controlled clinical trial. Medicine (Baltimore). 2024 Sep 13;103(37):e39325. doi: 10.1097/MD.0000000000039325. [PubMed:39287310 ]
  5. Fortunati F, Froidure A, Baldin P, Horsmans Y, Lanthier N, Dahlqvist G, Delire B: Pirfenidone-induced liver injury, a case report of a rare idiosyncratic reaction. Ther Adv Drug Saf. 2024 Sep 14;15:20420986241270866. doi: 10.1177/20420986241270866. eCollection 2024. [PubMed:39286238 ]